Nutex Health Q2 2024 GAAP EPS $(0.07) Beats $(0.29) Estimate, Sales $76.08M Beat $68.20M Estimate
Nutex Health Q2 2024 GAAP EPS $(0.07) Beats $(0.29) Estimate, Sales $76.08M Beat $68.20M Estimate
Nutex Health 2024財年第二季度每股收益爲$(0.07)，超出預期$(0.29)，銷售額爲7,608萬美元，超出預期6,820萬美元。
Nutex Health (NASDAQ:NUTX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.29) by 75.86 percent. The company reported quarterly sales of $76.08 million which beat the analyst consensus estimate of $68.20 million by 11.55 percent. This is a 29.12 percent increase over sales of $58.92 million the same period last year.
Nutex Health (納斯達克股票代碼：NUTX)報告每股虧損$(0.07)，超過分析師共識預期$(0.29)的75.86%。該公司報告季度銷售額爲7608萬美元，超過分析師共識預期6820萬美元，增長11.55%。這比去年同期的銷售額5892萬美元增長了29.12％。
資訊熱榜
更新時間